Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 2,513 shares, an increase of 29.6% from the February 12th total of 1,939 shares. Based on an average daily volume of 2,710 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily volume of 2,710 shares, the days-to-cover ratio is presently 0.9 days.

Hikma Pharmaceuticals Trading Up 5.1%

OTCMKTS:HKMPY opened at $33.43 on Tuesday. The business’s 50-day simple moving average is $40.50 and its 200-day simple moving average is $43.12. Hikma Pharmaceuticals has a fifty-two week low of $31.80 and a fifty-two week high of $56.94.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.